pdf Archives - Page 25 of 45

17 Aug Selective Serotonin Reuptake Inhibitors (SSRIS) and Serotonin–Norepinephrine Reuptake Inhibitors (SNRIS) associated with the risk of Postpartum Haemorrhage

Posted at 11:51h in

Novartis as directed by the South African Health Products Regulatory Authority (SAHPRA) would like to inform you about the increased incidence of intraocular inflammation (IOI) and related adverse events including retinal vasculitis (RV) and retinal vascular occlusion (RO) associated with (brolucizumab) when administered at 4...

17 Aug COVID-19 Vaccine Janssen

Posted at 11:50h in

Janssen Pharmaceutica (Pty) Ltd, as directed by the South African Health Products Regulatory Authority (SAHPRA) would like to inform you about new safety information that has resulted in contraindication of the COVID-19 Vaccine Janssen in individuals with a history of Capillary Leak Syndrome (CLS). ...

17 Aug COMIRNATY® (COVID-19 mRNA Vaccine) -Warning regarding rare cases of Myocarditis and Pericarditis

Posted at 11:44h in

Pfizer South Africa, in collaboration with the South African Health Products Regulatory Authority (SAHPRA) wish to inform you of the warning regarding rare cases of myocarditis and pericarditis reports that were noted following the use of COVID-19 mRNA vaccines, including Comirnaty® (Covid- 19 mRNA vaccine)....

17 Aug VSIQQ® (Brolucizumab) – A Requirement to Discontinue Treatment with Vsiqq® in Patients who Develop Retinal Vasculitis and/or Retinal Vascular Occlusion, Typically in the Presence of Intraocular Inflammation

Posted at 11:43h in

Novartis, as directed by the South African Health Products Regulatory Authority (SAHPRA), would like to inform you about the requirement to discontinue treatment with Vsiqq® in patients who develop retinal vasculitis and/or retinal vascular occlusion. Retinal vasculitis and retinal vascular occlusion are immune-mediated events, which...

17 Aug Topical Corticosteroid – Risk of Withdrawal Reactions – Aspen

Posted at 11:42h in

The following holders of certificates of registration (HCRs), Aspen Pharmacare, GlaxoSmithKline (Pty) Ltd and Glenmark Pharmaceuticals South Africa (Pty) Ltd, in collaboration with the South African Health Products Regulatory Authority (SAHPRA), wish to draw your attention to the following important safety information associated with topical...

15 Aug Guideline for Dental Radiography

Posted at 21:52h in

This guideline document determines basic requirements and recommendations for radiation protection and safety in dental radiography applications....

15 Aug Guideline Radiologist Available by Remote Digital Connection

Posted at 21:49h in

To provide guidance when applying to license to Use a Computed Tomography system where a Radiologist is available only by remote connection....

15 Aug Guideline For Code Of Practice For Users Of Non – Medical X-RAY Equipment – Forensic

Posted at 21:46h in

This guideline is intended to help healthcare professionals in the forensic field who are tasked with acquiring rays of deceased individuals to protect themselves from the dangers of ionizing radiation....

15 Aug Guideline for Code of Practise for Industrial Radiography X-Ray

Posted at 21:45h in

X-Ray equipment used in industrial radiography is subject to regulatory control in terms of Article 3(1) of the Hazardous Substances Act, 1973 (Act 15 of 1973), as amended. The body responsible for administering this legislation is SAHPRA: Radiation Control. This code of practice has been...

15 Aug Guideline for Bone Densitometer – Operators

Posted at 21:41h in

The following recommendations serve as guidelines for shielding, monitoring, and positioning of operators during dual-energy X-Ray absorptiometry (DXA)....

Archive